Biogen stock jumped into a buy zone Thursday after Medicare officials said they would pay for some Alzheimer's treatments.
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
INDIANAPOLIS , May 30, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 44th Annual Global Healthcare Conference, June 12-13, 2023. Anat Ashkenazi, Lilly executive
Eli Lilly and Novo Nordisk have been two of the hottest dividend-paying pharma stocks of late. While both companies sport well-supported dividends, one company comes with inherently less risk and stro
XtalPi said the drug candidates will target a disease that currently has no medicine available.
Novo Nordisk is struggling to keep up with demand for Wegovy. It's experiencing manufacturing problems and delaying new-patient starts.
No, you read this correctly – we're here to discuss overvalued value stocks to sell. Seemingly a contradiction in terms, a company that becomes overvalued by nature is no longer a value play.
The trillion-dollar club is an exceedingly rare group. In fact, there are only 5 companies on that list currently.
An analyst expects Lilly to launch a competitor in weight-loss drugs a year earlier than expected, giving Eli Lilly stock a chance to shine. The post Eli Lilly Could Launch Its Rival To Novo Nordisk's
A national obsession with a new class of weight-loss drugs is turning dangerous, doctors and researchers say, as many patients are inappropriately prescribed Wegovy, Ozempic and similar medications an

Should You Pick AbbVie Stock Over LLY?

07:00am, Friday, 26'th May 2023
Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices.
Now is a great time to start accumulating top biotech stocks. The biotech boom is red-hot.
The best-performing US big cap biopharma company this year still has lots of room to grow, according to brokers. Eli Lilly and Co (NYSE:LLY) “still offers one of the cleanest, de-risked growth stori

Two bullish calls on Eli Lilly

01:47pm, Wednesday, 24'th May 2023
The 'Halftime Report' traders debate the biggest analyst calls of the day.
Eli Lilly & Co (NYSE: LLY) has rallied over the past three months but a Bank of America analyst says it's not out of room to run just yet.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE